Stacey J. Davis
Corporate Officer/Principal chez XILIO THERAPEUTICS, INC.
Provenance du réseau au premier degré de Stacey J. Davis
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 22 | |
Johnson & Johnson Innovation - JJDC, Inc.
 Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.
21
| Subsidiary | Investment Managers | 21 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stacey J. Davis via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO | |
| University of California, Berkeley | College/University | Doctorate Degree Masters Business Admin Masters Business Admin Doctorate Degree | |
| TESARO INC | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Chairman Chief Operating Officer General Counsel | |
NeoTract, Inc.
 NeoTract, Inc. BiotechnologyHealth Technology NeoTract, Inc. develops surgical devices for urological and gynecological disorders. It offers UroLift System, a minimally invasive device to treat lower urinary tract symptoms due to benign prostatic hyperplasia. The company was founded by Joshua Makower, Joseph Catanese, Theodore C. Lamson and Earl A. Bright II in 2004 and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Chief Executive Officer President Corporate Officer/Principal | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Executive Officer President | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal | |
| INVIVYD, INC. | Biotechnology | Director/Board Member Founder | |
Xilio Therapeutics LLC
 Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Graduate Degree Undergraduate Degree | |
| LEGEND BIOTECH CORPORATION | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| University of Pennsylvania Medical Center | College/University | Corporate Officer/Principal Doctorate Degree | |
| GI DYNAMICS, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Stromedix, Inc.
 Stromedix, Inc. Pharmaceuticals: MajorHealth Technology Stromedix, Inc. develops novel drugs to treat fibrosis and fibrotic organ failure. The company was founded by Michael Gilman in 2006 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Cardiac Dimensions, Inc.
 Cardiac Dimensions, Inc. Medical SpecialtiesHealth Technology Cardiac Dimensions, Inc. develops novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. It offers the CARILLON Mitral Contour System, a proprietary and implantable device designed to be positioned in the coronary sinus vein using cardiac catheterization techniques. The firm also offers patient enrollment, clinical testing, and medical consulting services. The company was founded by James W. Fitzsimmons and Scott Jordan Wolf in 2001 and is headquartered in Kirkland, WA. | Medical Specialties | Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
CardioPolymers, Inc.
 CardioPolymers, Inc. Pharmaceuticals: MajorHealth Technology CardioPolymers, Inc. provides novel biocompatible polymer implant therapies to treat cronic heart failures. The company was founded in 2003 and is headquartered in Laguna Hills, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | Director of Finance/CFO Public Communications Contact | |
| GE AEROSPACE | Industrial Machinery | Corporate Officer/Principal Corporate Officer/Principal | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| CVRX, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
USGI Medical, Inc.
 USGI Medical, Inc. Medical SpecialtiesHealth Technology USGI Medical, Inc. develops technologies and tools to surgeons and gastroenterologists. It offers surgeons and gastroenterologists the tools they need to offer millions of potential patients a less invasive surgical option. The company was founded by Vahid C. Saadat and Eugene G. Chen in 2001 and is headquartered in San Clemente, CA. | Medical Specialties | Chief Executive Officer Chairman | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Renova Therapeutics, Inc.
 Renova Therapeutics, Inc. BiotechnologyHealth Technology Renova Therapeutics, Inc. operates as a biopharmaceutical company. The firm is developing definitive, one-time gene therapies and peptide infusion treatments to restore the health of people suffering from chronic diseases. Its product, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in patients with CHF. The company was founded by Jack W. Reich, H. Kirk Hammond and Craig Andrews in 2009 and is headquartered in San Diego, CA. | Biotechnology | President Corporate Officer/Principal | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| NEVRO CORP. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Public Communications Contact Chief Tech/Sci/R&D Officer | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio Partners LLC (venBio) is a private equity subsidiary of Venbio Partners LP founded in 2009 by Adelman robert and Goodman corey. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
LabVelocity
 LabVelocity Packaged SoftwareTechnology Services Part of Copyright Clearance Center, Inc., LabVelocity develops scientific software solutions. The company is based in Burlingame, CA. The company was founded by Erik Lium. LabVelocity was acquired by Infotrieve, Inc., part of Copyright Clearance Center, Inc. from November 06, 2014 on October 11, 2004. | Packaged Software | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Chief Executive Officer | |
Argo Capital Management Ltd.
 Argo Capital Management Ltd. Investment ManagersFinance Argo Capital Management Ltd. (Argo) is the Great Britain-based alternative investment management subsidiary of ACMH Ltd. in Cayman Islands. The firm was founded by Andreas Rialas in 2000. Headquartered in London, Argo provides asset management services to high net-worth clients. | Investment Managers | Corporate Officer/Principal | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Citigroup Global Markets, Inc. (Broker)
 Citigroup Global Markets, Inc. (Broker) Investment Banks/BrokersFinance Citigroup Global Markets, Inc. (Broker) (CGMI-Broker) is the broker/dealer division of Citigroup Global Markets, Inc., an investment bank headquartered in New York City with additional offices across the US. The firm was founded in 2004 and is a subsidiary of Citigroup Financial Products, Inc., ultimately held by Citigroup, Inc. (NYSE: C). CGMI-Broker covers all market capitalizations of the major global indices and provides macro and quantitative analysis of global markets and sector trends. Their core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis. | Investment Banks/Brokers | Institutional Sales | |
Stanford GSB Chapter of Hong Kong Ltd.
 Stanford GSB Chapter of Hong Kong Ltd. Miscellaneous Commercial ServicesCommercial Services Stanford GSB Chapter of Hong Kong Ltd. was founded in 2011. The private company is based in Hong Kong, Hong Kong. The Chinese company's mission is to provide a platform for engaged dialogue with prominent business, non-profit, philanthropic, cultural and thought leaders; to provide a foundation for life-long learning, mentoring and friendships; to foster new ideas and opportunities in the fields of business, technology, entrepreneurship, and social. | Miscellaneous Commercial Services | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 48 |
| Royaume-Uni | 3 |
| Hong Kong | 2 |
Sectorielle
| Health Technology | 34 |
| Consumer Services | 8 |
| Finance | 5 |
| Health Services | 3 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 168 |
| Corporate Officer/Principal | 101 |
| Independent Dir/Board Member | 41 |
| Undergraduate Degree | 36 |
| Chief Executive Officer | 35 |
Relations les plus connectées
| Insiders | |
|---|---|
| Michael Ross | 44 |
| Daniel Lynch | 32 |
| David P. Holveck | 22 |
| V. Kadhiresan | 21 |
| Roger J. Guidi | 20 |
| Tomas Jan Heyman | 18 |
| Marino Carol | 16 |
| Rami Elghandour | 15 |
| Allene Diaz | 14 |
| Paul Clancy | 14 |
| Roy C. Cosan | 12 |
| René Russo | 11 |
| Niamh Pellegrini | 11 |
| Jonathan Waldstreicher | 11 |
| Scott M. Moonly | 11 |
- Bourse
- Insiders
- Stacey J. Davis
- Connexions Sociétés
